Literature DB >> 19352117

Potent early immune response after kidney transplantation in patients of the European senior transplant program.

Johann Pratschke1, Vera Merk, Anja Reutzel-Selke, Andreas Pascher, Christian Denecke, Andreas Lun, Ali Said, Constanze Schönemann, Frank Ulrich, Petra Reinke, Ulrich Frei, Peter Neuhaus, Stefan G Tullius.   

Abstract

BACKGROUND: The increasing age of organ donors and the transplantation of older recipients have become clinical practice. Age-adapted immunosuppressive protocols considering these changes are currently not established. This study analyzed the age-dependent immune response after human kidney transplantation.
METHODS: One hundred renal allograft recipients were prospectively evaluated from 2004 to 2005. Patients older than 65 years of the European Senior Program receiving kidneys from donors older than 65 years were compared with recipients younger than 65 years receiving kidneys from donors younger than 65 years. Age-dependent modifications of the immune response were evaluated before transplantation and 7 days and 6 months after grafting by flow cytometry analysis of lymphocyte surface markers in peripheral blood. The cytokine pattern was determined by Cytometric Bead Array, T-cell alloreactivity by enzyme-linked immunospot analysis.
RESULTS: There were no differences between the groups regarding patient survival, graft survival, and function at 6 months after transplantation. Before transplantation, 7 days and 6 months thereafter recipients older than 65 years demonstrated significantly elevated numbers of memory T-cells while counts for naive T-cells were significantly reduced. Numbers of activated cytotoxic cells were elevated with increasing age before and 7 days after transplantation. T-cell alloreactivity was more pronounced in older recipients at all time points. Seven days after transplantation tumor necrosis factor-alpha (TNF-alpha) levels were significantly higher, whereas TNF-alpha and interleukin-10 (IL-10) concentrations were significantly reduced after 6 months in older recipients.
CONCLUSIONS: Our data demonstrate an initially pronounced immune response in elderly recipients receiving grafts from elderly donors. This observation supports the concept of a donor and recipient age-adapted immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352117     DOI: 10.1097/TP.0b013e31819ca0d7

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

Review 1.  Kidney transplantation and the ageing immune system.

Authors:  Dianne McKay; Julie Jameson
Journal:  Nat Rev Nephrol       Date:  2012-11-13       Impact factor: 28.314

2.  Profiling risk for acute rejection in kidney transplantation: recipient age is a robust risk factor.

Authors:  Abbas Rana; Bhamidipati Murthy; Zachery Pallister; Michael Kueht; Ronald Cotton; N Thao N Galvan; Whiston Etheridge; Hau Liu; John Goss; Christine O'Mahony
Journal:  J Nephrol       Date:  2016-09-29       Impact factor: 3.902

Review 3.  Renal transplantation with expanded criteria donors: Which is the optimal immunosuppression?

Authors:  Vassilis Filiopoulos; John N Boletis
Journal:  World J Transplant       Date:  2016-03-24

4.  Effects of cellular sensitization and donor age on acute rejection and graft function after deceased-donor kidney transplantation.

Authors:  Donald E Hricik; Emilio D Poggio; Kenneth J Woodside; Naragaju Sarabu; Edmund Q Sanchez; James A Schulak; Aparna Padiyar; Peter S Heeger; Joshua J Augustine
Journal:  Transplantation       Date:  2013-05-27       Impact factor: 4.939

5.  Managing transplant rejection in the elderly: the benefits of less aggressive immunosuppressive regimens.

Authors:  Kristian Heldal; Karsten Midtvedt
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

6.  Solid-organ transplantation in older adults: current status and future research.

Authors:  M Abecassis; N D Bridges; C J Clancy; M A Dew; B Eldadah; M J Englesbe; M F Flessner; J C Frank; J Friedewald; J Gill; C Gries; J B Halter; E L Hartmann; W R Hazzard; F M Horne; J Hosenpud; P Jacobson; B L Kasiske; J Lake; R Loomba; P N Malani; T M Moore; A Murray; M-H Nguyen; N R Powe; P P Reese; H Reynolds; M D Samaniego; K E Schmader; D L Segev; A S Shah; L G Singer; J A Sosa; Z A Stewart; J C Tan; W W Williams; D W Zaas; K P High
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

7.  Recipient-related predictors of kidney transplantation outcomes in the elderly.

Authors:  Parta Hatamizadeh; Miklos Z Molnar; Elani Streja; Paungpaga Lertdumrongluk; Mahesh Krishnan; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin Transplant       Date:  2013-03-21       Impact factor: 2.863

Review 8.  Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.

Authors:  Dirk R J Kuypers
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study.

Authors:  Kristian Heldal; Solveig Thorarinsdottir; Anders Hartmann; Torbjørn Leivestad; Anna V Reisæter; Aksel Espen Foss; Karsten Midtvedt
Journal:  Transplant Res       Date:  2013-06-26

10.  Benefit of kidney transplantation beyond 70 years of age.

Authors:  Kristian Heldal; Anders Hartmann; Diana C Grootendorst; Dinanda J de Jager; Torbjørn Leivestad; Aksel Foss; Karsten Midtvedt
Journal:  Nephrol Dial Transplant       Date:  2009-12-27       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.